Bionik Laboratories Corp. Quarterly Liabilities, Current in USD from Q3 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Bionik Laboratories Corp. quarterly Liabilities, Current history and growth rate from Q3 2011 to Q1 2023.
  • Bionik Laboratories Corp. Liabilities, Current for the quarter ending March 31, 2023 was $2.31M, a 54.8% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $2.31M +$817K +54.8% Mar 31, 2023 10-K 2023-06-21
Q4 2022 $2.09M -$8.06M -79.4% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $2.03M -$7.81M -79.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.69M -$2.05M -54.8% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.49M -$2.6M -63.6% Mar 31, 2022 10-K 2023-06-21
Q4 2021 $10.2M +$2.94M +40.7% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 $9.84M +$2.95M +42.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.74M -$3.25M -46.5% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $4.1M -$689K -14.4% Mar 31, 2021 10-K 2022-06-09
Q4 2020 $7.21M +$4.55M +171% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 $6.9M +$3.64M +112% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $7M +$2.84M +68.4% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $4.78M +$1.51M +46.3% Mar 31, 2020 10-K 2021-06-24
Q4 2019 $2.66M -$3.66M -57.9% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $3.26M +$1.26M +62.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $4.16M -$986K -19.2% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $3.27M -$4.85M -59.7% Mar 31, 2019 10-K 2020-06-30
Q4 2018 $6.32M -$3.99M -38.7% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 $2M -$5.08M -71.7% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $5.14M -$1.22M -19.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $8.12M +$3.3M +68.6% Mar 31, 2018 10-K 2019-07-01
Q4 2017 $10.3M +$5.65M +121% Dec 31, 2017 10-Q 2018-02-13
Q3 2017 $7.09M +$2.04M +40.4% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $6.37M -$699K -9.9% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $4.82M +$3.98M +476% Mar 31, 2017 10-K 2018-06-27
Q4 2016 $4.66M Dec 31, 2016 10-Q 2017-02-14
Q3 2016 $5.05M Sep 30, 2016 10-Q 2016-11-15
Q2 2016 $7.07M Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $837K +$295K +54.5% Mar 31, 2016 8-K 2017-12-21
Q1 2015 $542K +$525K +3163% Mar 31, 2015 8-K 2017-12-21
Q4 2014 $42.6K +$28.3K +199% Dec 31, 2014 10-K 2015-04-15
Q3 2014 $24.5K +$14.3K +141% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $21.6K +$14.7K +213% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $16.6K +$16.5K +10969% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $14.2K +$12.6K +763% Dec 31, 2013 10-K 2015-04-15
Q3 2013 $10.1K +$3.81K +60.2% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $6.92K +$400 +6.14% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $150* -$6.28K -97.7% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $1.65K* -$4.68K -73.9% Dec 31, 2012 10-K 2014-04-15
Q3 2012 $6.33K +$242 +3.97% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 $6.52K Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $6.43K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $6.33K Dec 31, 2011 10-K 2013-03-06
Q3 2011 $6.09K Sep 30, 2011 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.